Satsuma Pharmaceuticals I... (STSA)

NASDAQ: STSA · Real-Time Price · USD

1.10

0.00 (0.00%)

At close: Jun 07, 2023, 8:00 PM

Satsuma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-66.17M	-70.95M	-62.91M	-60.84M	-56.26M	-51.17M	-48.09M	-46.93M	-46.61M	-48.33M	-47.12M	-43.42M	-38.34M	-28.88M	-19.89M	-13.02M	-6.6M	-3.88M	-1.6M
Interest Income	1.34M	905K	476K	240K	147K	157K	203K	379K	663K	1.11M	1.62M	1.75M	1.67M	1.19M	628K	310K	60K	39K	13K
Pretax Income	-64.83M	-70.06M	-62.44M	-60.64M	-56.21M	-51.17M	-48.13M	-46.84M	-46.02M	-47.31M	-45.64M	-41.86M	-37.13M	-28.18M	-19.71M	-13.04M	-6.75M	-3.93M	-1.59M
Net Income	-63.33M	-69M	-62.01M	-60.48M	-56.18M	-51.17M	-48.13M	-46.84M	-46.02M	-47.31M	-45.64M	-41.86M	-37.13M	-28.18M	-19.71M	-13.04M	-6.75M	-3.93M	-1.59M
Selling & General & Admin	14.45M	15.13M	15.65M	14.75M	14.23M	13.53M	13.28M	13.54M	12.83M	12.06M	10.74M	8.35M	6.64M	4.68M	2.89M	2.08M	1.11M	550K	220K
Research & Development	39.99M	44.09M	47.26M	46.09M	42.03M	37.63M	34.81M	33.39M	33.78M	36.27M	36.38M	35.07M	31.69M	24.2M	17M	10.94M	5.48M	3.33M	1.38M
Other Expenses	11.73M	11.73M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	54.44M	59.22M	62.91M	60.84M	56.26M	51.17M	48.09M	46.93M	46.61M	48.33M	47.12M	43.42M	38.34M	28.88M	19.89M	13.02M	6.6M	3.88M	1.6M
Interest Expense	-203K	282K	306K	72K	117K	163K	209K	256K	303K	350K	397K	436K	464K	482K	453K	332K	210K	88K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	54.44M	59.22M	62.91M	60.84M	56.26M	51.17M	48.09M	46.93M	46.61M	48.33M	47.12M	43.42M	38.34M	28.88M	19.89M	13.02M	6.6M	3.88M	1.6M
Income Tax Expense	-1.5M	-1.05M	-430K	-135K	38K	91K	170K	353K	887K	1.36M	1.87M	1.99M	1.67M	1.19M	633K	315K	62K	41K	13K
Shares Outstanding (Basic)	33.15M	33.13M	31.86M	31.55M	31.55M	31.53M	31.53M	31.53M	21.98M	17.43M	17.42M	17.39M	17.38M	17.37M	3.66M	16.11M	6.8M	6.8M	6.8M
Shares Outstanding (Diluted)	33.15M	33.13M	31.86M	31.55M	31.55M	31.53M	31.53M	31.53M	21.98M	17.43M	17.42M	17.39M	17.38M	17.37M	3.66M	16.11M	6.8M	6.8M	6.8M
EPS (Basic)	-1.96	-2.15	-1.96	-1.91	-1.78	-1.77	-2	-2.27	-2.52	-2.72	-2.62	-4.19	-3.95	-3.68	-3.4	-1.37	-0.98	-0.57	-0.23
EPS (Diluted)	-1.96	-2.15	-1.96	-1.91	-1.78	-1.77	-2	-2.27	-2.52	-2.72	-2.62	-4.19	-3.95	-3.68	-3.4	-1.37	-0.98	-0.57	-0.23
EBITDA	-52.73M	-57.85M	-61.84M	-60.08M	-55.64M	-50.61M	-47.56M	-46.26M	-45.45M	-46.72M	-45.04M	-41.24M	-36.51M	-27.55M	-19.13M	-12.6M	-6.46M	-3.8M	-1.57M
EBIT	-54.52M	-70.03M	-62.14M	-60.57M	-56.09M	-51.01M	-47.92M	-46.58M	-45.72M	-46.96M	-45.25M	-41.42M	-36.67M	-27.69M	-19.26M	-11.12M	n/a	n/a	n/a
Depreciation & Amortization	13.44M	13.1M	1.08M	728K	556K	467K	363K	318K	270K	239K	207K	183K	159K	141K	128K	105K	72K	41K	15K